Chromosome 9p deletions are an independent predictor of tumor progression following nephrectomy in patients with localized clear cell renal cell carcinoma (2014)
- Authors:
- USP affiliated authors: SROUGI, MIGUEL - FM ; DALL'OGLIO, MARCOS FRANCISCO - FM
- Unidade: FM
- DOI: 10.1016/j.urolonc.2013.12.008
- Subjects: NEOPLASIAS RENAIS; CARCINOMA; HIBRIDIZAÇÃO; NEFRECTOMIA; CROMOSSOMOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Urologic Oncology
- ISSN: 1078-1439
- Volume/Número/Paginação/Ano: v. 32, n. 5, p. 601-606, 2014
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
OLIVEIRA, Daniel de et al. Chromosome 9p deletions are an independent predictor of tumor progression following nephrectomy in patients with localized clear cell renal cell carcinoma. Urologic Oncology, v. 32, n. 5, p. 601-606, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.urolonc.2013.12.008. Acesso em: 06 maio 2026. -
APA
Oliveira, D. de, Dall’Oglio, M. F., Reis, S. T., Zerati, M., Souza, I. C., Leite, K. R., & Srougi, M. (2014). Chromosome 9p deletions are an independent predictor of tumor progression following nephrectomy in patients with localized clear cell renal cell carcinoma. Urologic Oncology, 32( 5), 601-606. doi:10.1016/j.urolonc.2013.12.008 -
NLM
Oliveira D de, Dall’Oglio MF, Reis ST, Zerati M, Souza IC, Leite KR, Srougi M. Chromosome 9p deletions are an independent predictor of tumor progression following nephrectomy in patients with localized clear cell renal cell carcinoma [Internet]. Urologic Oncology. 2014 ; 32( 5): 601-606.[citado 2026 maio 06 ] Available from: https://doi.org/10.1016/j.urolonc.2013.12.008 -
Vancouver
Oliveira D de, Dall’Oglio MF, Reis ST, Zerati M, Souza IC, Leite KR, Srougi M. Chromosome 9p deletions are an independent predictor of tumor progression following nephrectomy in patients with localized clear cell renal cell carcinoma [Internet]. Urologic Oncology. 2014 ; 32( 5): 601-606.[citado 2026 maio 06 ] Available from: https://doi.org/10.1016/j.urolonc.2013.12.008 - PGC and PSMA in prostate cancer diagnosis: tissue analysis from biopsy samples
- Matrix metalloproteinase-2 polymorphism is associated with prognosis in prostate cancer
- Are we able to correctly identify prostate cancer patients who could be adequately treated by focal therapy?
- Robotic-assisted laparoscopic partial nephrectomy: initial experience in Brazil and a review of the literature
- Micro RNA expression in the development of prostate cancer. From prostatic intraepithelial neoplasia to metastases
- Expression profile of microrna-145 in urothelial bladder cancer
- Correlation between cell adhesion molecules expression and tumor outcome in prostate cancer
- Immune expression of E-cadherin and α, β and γ-Catenin adhesion molecules and prognosis for upper urinary tract urothelial carcinomas
- Carbonic Anhydrase IX is Not a Predictor of Outcomes in Non-Metastatic Clear Cell Renal Cell Carcinoma - A Digital Analysis of Tissue Microarray
- Hiperplasia benigna da próstata
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
